HYBRID EVENT: You Can Participate In Person At Berlin, Germany Or Virtually From Your Home Or Work
ICOCTI · Registering as Listener

International Conference on Oncology and Cancer Treatment Innovations

24–25 Oct 2026 Berlin, Germany Standard / Physical Participation
Listener Registration
$169
virtual · $259 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.
Apply
Try FAST10 for 10% off on eligible registrations.

1. Policy on Cancellations & Refunds :

  • A full refund is possible only if the cancellation request is submitted at least 70 days before the conference, with formal paperwork completed at least 60 days prior.
  • If cancellation occurs between 60 and 30 days before the event, partial refunds may be granted based on administrative costs incurred.
  • Cancellations made within 30 days of the event are non-refundable, though participants will receive a credit valid for one year.
  • Registrations made less than 30 days before the event are not eligible for refunds, but may be transferred to another ISIT conference.
  • Since this conference is hybrid format, the organizer reserves the right to conduct the event either in-person or virtually. Please note that no refunds will be issued due to changes in the event format.
  • Virtual registration fees are non-refundable. A credit will instead be issued for use at a future conference event.

2. Participation & Registration Requirements :

  • To attend an ISIT event, participants must complete the registration process within the stipulated time.
  • The event schedule, venue, and format are subject to changes at the discretion of the organizers, with prior notice sent via email.
  • ISIT is not liable for any financial losses resulting from changes in event details.
  • Fees paid for registration are strictly non-refundable.
  • If the primary author cannot participate, a co-author may attend instead, but refunds will not be granted for non-attendance.

3. Submission & Publication Norms :

  • Researchers submitting papers to ISIT must ensure their institution or supervisor is aware of their submission.
  • Each submission is subject to a rigorous peer review before being accepted for presentation.
  • Only papers linked to a completed registration will be included in conference proceedings.
  • The submitting author is considered the primary author; ISIT does not verify individual authorship claims.
  • If any concerns regarding authorship arise and are validated, the paper will be withdrawn without reconsideration.
  • Once a paper is removed, it cannot be reintroduced into any ISIT publication.

4. Travel & Accommodation Responsibilities :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.

5. Visa & Invitation Letter Policy :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.
  • ISIT does not engage directly with consulates or embassies on behalf of attendees.
  • Participants must handle their own visa applications and processes.
  • Important Information Regarding Invitation Letters:
    • The invitation letter is provided solely for conference attendance and does not serve as a document for immigration, employment, or residency purposes.
    • The letter assists in visa applications but does not guarantee visa approval.
    • ISIT holds no responsibility for visa denials or processing delays, and all related costs are borne by the applicant.
    • Any alterations or unauthorized use of the invitation letter will result in its invalidation and possible cancellation of conference participation.
    • Legal action may be pursued if the document is misused.
    • By accepting the invitation letter, attendees agree to comply with international travel regulations and ethical participation standards.

6. Registration Transfers :

  • Registrations may be transferred to another individual from the same institution if the original participant cannot attend.
  • Transfer requests must be made via email to info@isit.org.in with necessary details and supporting documents.
  • Transfers must be requested at least 14 days before the event; otherwise, they will not be accommodated.
  • Transferred registrations are not eligible for refunds.

7. General Considerations :

  • Any modifications or cancellations must be communicated in writing to info@isit.org.in.
  • Registration confirms acknowledgment and acceptance of these policies.
  • ISIT does not initiate automatic transactions; all payments are voluntarily completed by registrants.
  • Once registered, participants must submit a conference registration form within three days for confirmation.
  • Travel plans should only be finalized after receiving the official conference itinerary, which will be shared 15 days before the event.
Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the event.
View all 11 tracks →
This track will explore the latest advancements in immunotherapy for cancer treatment, focusing on novel approaches and therapies. Discussions will include the mechanisms of action, clinical outcomes, and future directions in immunotherapeutic strategies.
This session will delve into the role of precision medicine in oncology, emphasizing personalized treatment plans based on genetic and molecular profiling. Participants will examine case studies and emerging technologies that enhance targeted therapies.
This track will highlight the importance of translational research in oncology, focusing on how laboratory discoveries can be effectively translated into clinical applications. Experts will discuss successful case studies and the challenges faced in this critical process.
This session will investigate the complexities of tumor biology and the tumor microenvironment, including cellular interactions and signaling pathways. Researchers will present findings on how these factors influence cancer progression and treatment responses.
This track will focus on innovative designs and methodologies in clinical trials for oncology treatments. Participants will discuss the implications of adaptive trial designs, patient recruitment strategies, and the integration of real-world evidence.
This session will cover the fundamental mechanisms underlying cancer biology, including genetic mutations and epigenetic modifications. Researchers will present novel therapeutic targets and their potential implications for treatment.
This track will address the intersection of health policy and oncology, focusing on the implications of policy decisions on cancer care delivery. Discussions will include access to treatments, healthcare disparities, and the impact of legislation on patient outcomes.
This session will explore cutting-edge technologies that are shaping the future of cancer treatment, including artificial intelligence and machine learning applications. Experts will discuss how these innovations can enhance diagnosis, treatment planning, and patient monitoring.
This track will focus on the unique challenges and innovative approaches in pediatric oncology. Participants will discuss recent advancements in treatment modalities and the importance of addressing the long-term effects of cancer therapies in children.
This session will examine strategies for cancer prevention and the importance of early detection in improving patient outcomes. Researchers will present findings on screening methods, risk assessment, and public health initiatives aimed at reducing cancer incidence.
This track will explore integrative approaches that combine conventional oncology treatments with complementary therapies. Discussions will focus on the evidence supporting these methods and their impact on patient quality of life and treatment efficacy.